Doxazosin Tablet
Product Images NDC 50090-5773

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Doxazosin (NDC 50090-5773). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Table 1 (Doxazosin Fig1)

Data table summarizing effectiveness results from placebo-controlled clinical trials of Doxazosin. It shows symptom scores and maximum flow rate changes at baseline and after treatment for different doses compared to placebo across three studies, including titration phases and fixed dose treatments. The data includes statistical significance markers and footnotes explaining study parameters.*

FDA Label Image

Figure 1 – Study 1 (Doxazosin Fig2)

Two line graphs showing clinical study results for Doxazosin 2 mg oral tablets. The left graph depicts mean change in total symptom score from baseline over 14 weeks, indicating greater symptom improvement with Doxazosin than placebo. The right graph shows mean increase in maximum urinary flow rate (mL/sec) from baseline over 14 weeks, with Doxazosin treatment demonstrating a larger flow rate increase compared to placebo. Both graphs include error bars and statistical significance markers.*

FDA Label Image

Chemical Structure (Doxazosin Str)

Chemical structure diagram of doxazosin mesylate, the active ingredient in the drug product Doxazosin. The diagram shows the molecular arrangement including methoxy groups, an amine group, and a mesylate moiety.*

FDA Label Image

Label Image (Lbl500905773)

Label for Doxazosin 2 mg oral tablets by A-S Medication Solutions, package containing 30 tablets. The label includes product identification, active ingredient as doxazosin mesylate USP equivalent to 2 mg doxazosin, storage instructions to keep at 68 to 77 degrees Fahrenheit, and prescribing information reference to the package insert.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.